Differential expression of hypertension-associated micrornas in the plasma of patients with white coat hypertension

Medicine (United States)

Volumn 94, Issue 13, 2015, Pages

  Cengiz, Mahir ^a   Karatas, Omer Faruk ^a,b   Koparir, Erkan ^a   Yavuzer, Serap ^a   Ali, Chayar ^a   Yavuzer, Hakan ^a   Kirat, Emre ^a   Karter, Yesari ^a   Ozen, Mustafa ^a,c,d  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ERZURUM TECHNICAL UNIVERSITY   (Turkey)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d BIRUNI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MICRORNA; MICRORNA 122; MICRORNA 125A; MICRORNA 126; MICRORNA 130; MICRORNA 155; MICRORNA 195; MICRORNA 21; MICRORNA 296 5P; MICRORNA 637; THYROTROPIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; UPREGULATION; WHITE COAT HYPERTENSION; BIOSYNTHESIS; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION;

ADULT; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; POLYMERASE CHAIN REACTION; UP-REGULATION; WHITE COAT HYPERTENSION;

EID: 84929462337     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000693     Document Type: Article

References (30)

1. Kearney PM, Whelton M, Reynolds K, et al. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22:11-19
2. Perlini S, Grassi G. Hypertension-related target organ damage: is it a continuum? J Hypertens. 2013;31:1083-1085.
3. Pickering TG, James GD, Boddie C, et al. How common is white coat hypertension? JAMA. 1988;259:225-228.
4. Franklin SS, Thijs L, Hansen TW, et al. White-coat hypertension: new insights from recent studies. Hypertension. 2013;62:982-987.
5. Nakashima T, Yamano S, Sasaki R, et al. White-coat hypertension contributes to the presence of carotid arteriosclerosis. Hypertens Res. 2004;27:739-745.
6. Yavuzer S, Yavuzer H, Cengiz M, et al. Endothelial damage in white coat hypertension: role of lectin-like oxidized low-density lipoprotein-1. J Hum Hypertens. 2015;29:92-98.
7. Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens. 2011;24:52-58.
8. Mancia G, Facchetti R, Bombelli M, et al. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006;47:846-853.
9. Fernandes T, Magalhães FC, Roque FR, et al. Exercise training prevents the microvascular rarefaction in hypertension balancing angiogenic and apoptotic factors: role of microRNAs-16,-21, and-126. Hypertension. 2012;59:513-520.
10. Yang Z, Kaye DM. Mechanistic insights into the link between a polymorphism of the 30UTR of the SLC7A1 gene and hypertension. Hum Mutat. 2009;30:328-333.
11. Li D, Yang P, Xiong Q, et al. MicroRNA-125a/b-5p inhibits endothelin-1 expression in vascular endothelial cells. J Hypertens. 2010;28:1646-1654.
12. Karolina DS, Tavintharan S, Armugam A, et al. Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab. 2012;97:E2271-E2276.
13. Sun HX, Zeng DY, Li RT, et al. Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase. Hypertension. 2012;60:1407-1414.
14. Zhu H, Yang Y, Wang Y, et al. MicroRNA-195 promotes palmitateinduced apoptosis in cardiomyocytes by down-regulating Sirt1. Cardiovasc Res. 2011;92:75-84.
15. Li S, Zhu J, Zhang W, et al. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation. 2011;124:175-184.
16. O'Connor DT, Zhu G, Rao F, et al. Heritability and genome-wide linkage in US and Australian twins identify novel genomic regions controlling chromogranin a: implications for secretion and blood pressure. Circulation. 2008;118:247-257.
17. O'Brien E, Waeber B, Parati G, et al. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ. 2001;322:531-536.
18. O'Brien E, Coats A, Owens P, et al. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society. BMJ. 2000;320:1128-1134.
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-408.
20. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:480-486.
21. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC practice guidelines for the management of arterial hypertension. Blood Press. 2014;23:3-16.
22. Thum T, Gross C, Fiedler J, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature. 2008;456:980-984.
23. Zhong X, Chung AC, Chen HY, et al. Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol. 2011;22:1668-1681.
24. Kontaraki JE, Marketou ME, Zacharis EA, et al. Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension. J Hum Hypertens. 2014;28:510-516.
25. Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777-1783.
26. Mao J, Li C, Zhang Y, et al. Human with-no-lysine kinase-4 30-UTR acting as the enhancer and being targeted by miR-296. Int J Biochem Cell Biol. 2010;42:1536-1543.
27. Wang S, Aurora AB, Johnson BA, et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008;15:261-271.
28. Martin MM, Lee EJ, Buckenberger JA, et al. MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J Biol Chem. 2006;281:18277-18284.
29. Long G, Wang F, Duan Q, et al. Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction. PLoS One. 2012;7:e50926.
30. Sung SH, Cheng HM, Wang KL, et al. White coat hypertension is more risky than prehypertension: important role of arterial wave reflections. Hypertension. 2013;61:1346-1353.